Study of ARQ 197 in Hepatocellular Carcinoma (HCC)

NCT01656265 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Hepatocellular Carcinoma

Interventions

DRUG: ARQ 197

Sponsor

Kyowa Kirin Co., Ltd.